Gynaecologic oncology topics for General Physicians
How gynecologic oncology & screening is tested
Written for DHA, SMLE, DOH, QCHP, OMSB, MOH, NHRA and Kuwait MOH — the same GP licensing mix, not a gynecologic oncology & screening specialist paper.
Oncology for GPs is postmenopausal bleeding until cancer is excluded, ovarian mass risk scores, and when to refer — not chemotherapy cycles.
PMB is TVUS endometrial thickness then biopsy. Ovarian cysts use size, complexity and tumour markers in context (RMI/IOTA ideas). Endometrial cancer risk is unopposed oestrogen.
BRCA is family history and referral, not a GP-ordered full genome. Vulval lesions that do not heal are biopsied.
Postmenopausal bleeding — first imaging?
Transvaginal ultrasound. A thin endometrium is reassuring; a thick one needs histology. Do not reassure without the scan.
Simple ovarian cyst in a premenopausal woman?
Often observe if small and simple. Complex, large, or postmenopausal masses are a different pathway.
CA-125 — screening test?
No. It helps in a mass already found. Using it to “screen” well women is the distractor.
More Gynae subspecialties